Citation: Ej. Arts et al., MECHANISMS OF CLINICAL RESISTANCE BY HIV-I VARIANTS TO ZIDOVUDINE ANDTHE PARADOX OF REVERSE-TRANSCRIPTASE SENSITIVITY, DRUG RESISTANCE UPDATES, 1(1), 1998, pp. 21-28
Authors:
ARTS EJ
QUINONESMATEU ME
ALBRIGHT JL
MAROIS JP
HOUGH C
GU ZX
WAINBERG MA
Citation: Ej. Arts et al., 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) MEDIATES CROSS-RESISTANCE TO NUCLEOSIDE ANALOGS IN THE CASE OF AZT-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, Journal of virology, 72(6), 1998, pp. 4858-4865
Authors:
QUINONESMATEU ME
ALBRIGHT JL
MAS A
SORIANO V
ARTS EJ
Citation: Me. Quinonesmateu et al., ANALYSIS OF POL GENE HETEROGENEITY, VIRAL QUASI-SPECIES, AND DRUG-RESISTANCE IN INDIVIDUALS INFECTED WITH GROUP-O STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology (Print), 72(11), 1998, pp. 9002-9015
Authors:
ARTS EJ
MILLER JT
EHRESMANN B
LEGRICE SFJ
Citation: Ej. Arts et al., MUTATING A REGION OF HIV-1 REVERSE-TRANSCRIPTASE IMPLICATED IN TRNA(LYS-3) BINDING AND THE CONSEQUENCES FOR (-)-STRAND DNA-SYNTHESIS, The Journal of biological chemistry, 273(23), 1998, pp. 14523-14532
Citation: Ej. Arts et Ma. Wainberg, MECHANISMS OF NUCLEOSIDE ANALOG ANTIVIRAL ACTIVITY AND RESISTANCE DURING HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTION, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 527-540
Authors:
ARTS EJ
STETOR SR
LI XG
RAUSCH JW
HOWARD KJ
EHRESMANN B
NORTH TW
WOHRL BM
GOODY RS
WAINBERG MA
LEGRICE SFJ
Citation: Ej. Arts et al., INITIATION OF (-) STRAND DNA-SYNTHESIS FROM TRNA(3)(LYS) ON LENTIVIRAL RNAS - IMPLICATIONS OF SPECIFIC HIV-1 RNA-TRNA(3)(LYS) INTERACTIONS INHIBITING PRIMER UTILIZATION BY RETROVIRAL REVERSE TRANSCRIPTASES, Proceedings of the National Academy of Sciences of the United Statesof America, 93(19), 1996, pp. 10063-10068
Authors:
LI XG
QUAN YD
ARTS EJ
LI Z
PRESTON BD
DEROCQUIGNY H
ROQUES BP
DARLIX JL
KLEIMAN L
PARNIAK MA
WAINBERG MA
Citation: Xg. Li et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NUCLEOCAPSID PROTEIN (NCP7) DIRECTS SPECIFIC INITIATION OF MINUS-STRAND DNA-SYNTHESIS PRIMED BY HUMAN TRNA(3)(LYS) IN-VITRO - STUDIES OF VIRAL-RNA MOLECULES MUTATED IN REGIONS THAT FLANK THE PRIMER BINDING-SITE, Journal of virology, 70(8), 1996, pp. 4996-5004
Authors:
ARTS EJ
MAROIS JP
GU ZX
LEGRICE SFJ
WAINBERG MA
Citation: Ej. Arts et al., EFFECTS OF 3'-DEOXYNUCLEOSIDE 5'-TRIPHOSPHATE CONCENTRATIONS ON CHAINTERMINATION BY NUCLEOSIDE ANALOGS DURING HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 REVERSE TRANSCRIPTION OF MINUS-STRAND STRONG-STOP DNA, Journal of virology, 70(2), 1996, pp. 712-720
Citation: Jw. Rausch et al., INVOLVEMENT OF C-TERMINAL STRUCTURAL ELEMENTS OF EQUINE INFECTIOUS-ANEMIA VIRUS REVERSE-TRANSCRIPTASE IN DNA-POLYMERASE AND RIBONUCLEASE-H ACTIVITIES, Journal of Molecular Biology, 257(3), 1996, pp. 500-511
Authors:
ARTS EJ
GHOSH M
JACQUES PS
EHRESMANN B
LEGRICE SFJ
Citation: Ej. Arts et al., RESTORATION OF TRNA(3)(LYS)-PRIMED (-)-STRAND DNA-SYNTHESIS TO AN HIV-1 REVERSE-TRANSCRIPTASE MUTANT WITH EXTENDED TRANSFER-RNAS - IMPLICATIONS FOR RETROVIRAL REPLICATION, The Journal of biological chemistry, 271(15), 1996, pp. 9054-9061
Authors:
WAINBERG MA
GU ZX
SALOMON H
ARTS EJ
KLEIMAN L
PARNIAK MA
MORIN N
Citation: Ma. Wainberg et al., MOLECULAR-BASIS AND CLINICAL-SIGNIFICANCE OF HIV-1 RESISTANCE TO NUCLEOSIDE COMPOUNDS, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 318(3), 1995, pp. 315-328
Citation: Zx. Gu et al., MUTATED K65R RECOMBINANT REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SHOWS DIMINISHED CHAIN TERMINATION IN THE PRESENCE OF2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE AND OTHER DRUGS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2760-2764
Citation: Zx. Gu et al., EFFECTS OF NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CELL-FREE RECOMBINANT REVERSE-TRANSCRIPTASE ASSAYS, The Journal of biological chemistry, 270(52), 1995, pp. 31046-31051
Citation: Ej. Arts et al., MATURE REVERSE-TRANSCRIPTASE (P66 P51) IS RESPONSIBLE FOR LOW-LEVELS OF VIRAL-DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)/, Leukemia, 8, 1994, pp. 190000175-190000178
Citation: Ej. Arts et Ma. Wainberg, PREFERENTIAL INCORPORATION OF NUCLEOSIDE ANALOGS AFTER TEMPLATE SWITCHING DURING HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE TRANSCRIPTION, Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 1008-1016
Authors:
LI XG
MAK J
ARTS EJ
GU ZX
KLEIMAN L
WAINBERG MA
PARNIAK MA
Citation: Xg. Li et al., EFFECTS OF ALTERATIONS OF PRIMER-BINDING SITE SEQUENCES ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION, Journal of virology, 68(10), 1994, pp. 6198-6206
Citation: Ej. Arts et al., DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES MAY NOT BEREQUIRED FOR INFECTIVITY, Journal of General Virology, 75, 1994, pp. 1605-1613
Authors:
GU ZX
FLETCHER RS
ARTS EJ
WAINBERG MA
PARNIAK MA
Citation: Zx. Gu et al., THE K65R MUTANT REVERSE-TRANSCRIPTASE OF HIV-1 CROSS-RESISTANT TO 2',3'-DIDEOXYCYTIDINE, 2',3'-DIDEOXY-3'-THIACYTIDINE, AND 2',3'-DIDEOXYINOSINE SHOWS REDUCED SENSITIVITY TO SPECIFIC DIDEOXYNUCLEOSIDE TRIPHOSPHATE INHIBITORS IN-VITRO, The Journal of biological chemistry, 269(45), 1994, pp. 28118-28122
Authors:
ARTS EJ
LI XG
GU ZX
KLEIMAN L
PARNIAK MA
WAINBERG MA
Citation: Ej. Arts et al., COMPARISON OF DEOXYOLIGONUCLEOTIDE AND TRNA(LYS-3) AS PRIMERS IN AN ENDOGENOUS HUMAN IMMUNODEFICIENCY VIRUS-1 IN-VITRO REVERSE TRANSCRIPTION TEMPLATE-SWITCHING REACTION, The Journal of biological chemistry, 269(20), 1994, pp. 14672-14680
Citation: Ej. Arts et Ma. Wainberg, THE KINETICS OF THE 1ST TEMPLATE SWITCH AND INHIBITION BY NUCLEOSIDE ANALOGS, Journal of cellular biochemistry, 1993, pp. 11-11
Authors:
GELEZIUNAS R
ARTS EJ
BOULERICE F
GOLDMAN H
WAINBERG MA
Citation: R. Geleziunas et al., EFFECT OF 3'-AZIDO-3'-DEOXYTHYMIDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN HUMAN FETAL BRAIN MACROPHAGES, Antimicrobial agents and chemotherapy, 37(6), 1993, pp. 1305-1312